Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Cannabis GXP is a professional consulting firm headquartered in Israel, positioned as a global advisor for GxP/GMP compliance, manufacturing, R&D, and regulatory market access in the cannabis industry. According to the website, its clients include cultivators, research institutions, product manufacturers, and new entrants looking to move into the cannabis sector. It is worth noting that this is not a SaaS product or enterprise software in the traditional sense, but an expert-led compliance and engineering consulting service.
Its service coverage is fairly comprehensive: from cannabis product development, delivery systems, and clinical trials, to conceptual and detailed design of cultivation, manufacturing, and laboratory facilities; as well as quality management systems, SOPs, GMP/GDP/ISO systems, staff training, validation plans, mock audits, and support during external regulatory audits. The website also mentions support for QC laboratory design, ISO 17025, GLP, data integrity, CAPA, deviation investigations, process validation, cleaning validation, and software/computerized system validation, with a clear focus on pharmaceutical-grade compliance implementation.
The website does not disclose packages, pricing, subscriptions, or free trial information. It is likely delivered by project, consulting hours, or milestone phases, but the text does not state this explicitly, so it should not be treated as a confirmed conclusion. For buyers, the evaluation should focus on project scope, consultant credentials, adaptation to local regulations, deliverables, responsibility boundaries for audit outcomes, and confidentiality terms.
Its strengths lie in a long service chain covering the end-to-end path from facility design to product approval, with an emphasis on biopharma, cannabis therapeutics, GMP, and regulatory experience. Client testimonials also suggest involvement in projects such as extraction process scale-up, GMP facilities, and ISO 17025 laboratory accreditation. The limitations are the lack of software-related capabilities: there is no information about APIs, permissions, integrations, cloud deployment, or self-hosting. Pricing, payment methods, project timelines, and service SLAs are also not public, which limits procurement transparency.
It is best suited to companies operating in legally regulated markets for cannabis cultivation, manufacturing, laboratory testing, or product R&D, especially teams that need to build GMP/GDP/GACP/ISO systems and prepare for audits. Access from China cannot be determined from the website text and should be marked as unknown. Given China’s strict regulation of cannabis and related businesses, domestic companies that only need compliance systems, cleanroom facilities, LIMS/QMS/MES, or ISO 17025 capabilities may want to first compare local pharmaceutical GMP consulting, laboratory accreditation consulting, and enterprise software alternatives.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cannabisgxp.com official site.
cannabisgxp.com is an Israel Legal & Tax provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach cannabisgxp.com directly.